|
ZNF239 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.369960E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.708990E-01 |
| Normal-vs-Stage2 |
1.399160E-01 |
| Normal-vs-Stage3 |
6.392200E-02 |
| Normal-vs-Stage4 |
6.805800E-01 |
| Stage1-vs-Stage2 |
6.833200E-01 |
| Stage1-vs-Stage3 |
5.013400E-01 |
| Stage1-vs-Stage4 |
4.548400E-01 |
| Stage2-vs-Stage3 |
9.372600E-01 |
| Stage2-vs-Stage4 |
3.963200E-01 |
| Stage3-vs-Stage4 |
2.996600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.195650E-01 |
| Normal-vs-AfricanAmerican |
2.019600E-01 |
| Normal-vs-Asian |
4.439800E-01 |
| Caucasian-vs-AfricanAmerican |
8.840000E-01 |
| Caucasian-vs-Asian |
2.049900E-02 |
| AfricanAmerican-vs-Asian |
6.215600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.696000E-02 |
| Normal-vs-Female |
2.519000E-01 |
| Male-vs-Female |
1.405030E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.206000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.528000E-02 |
| Normal-vs-Age(61-80Yrs) |
2.538400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.212800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.175800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.983000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.875600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.025600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.629200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.193600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.268200E-01 |
| Classical-VS-Follicular |
6.239100E-03 |
| Classical-VS-Other |
4.738800E-01 |
| Classical-VS-Normal |
5.115400E-01 |
| Tall-VS-Follicular |
3.821400E-01 |
| Tall-VS-Other |
8.092600E-01 |
| Tall-VS-Normal |
1.544400E-01 |
| Follicular-VS-Other |
8.493600E-01 |
| Follicular-VS-Normal |
1.435830E-02 |
| Other-VS-Normal |
3.171400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.318100E-02 |
| Normal-vs-N1 |
2.744800E-01 |
| N0-vs-N1 |
7.613400E-01 |
|
|
